Morgan Stanley Bio Sig Technologies, Inc. Transaction History

Morgan Stanley

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.26 - $0.62 $2,550 - $6,082	9,810 New	9,810 $4,000
Q4 2023 Feb 13, 2024	SELL	$0.26 - $0.62 $457 - $1,091	-1,760 Reduced 15.21%	9,810 $4,000
Q2 2023 Aug 14, 2023	BUY	$1.07 - $1.55 $1,765 - $2,557	1,650 Added 16.63%	11,570 $14,000
Q1 2023 May 15, 2023	SELL	$0.42 - $1.4 $1,680 - $5,601	-4,001 Reduced 28.74%	9,920 $11,000
Q4 2022 Feb 14, 2023	SELL	$0.31 - $8.8 $4,461 - $126,649	-14,392 Reduced 50.83%	13,921 $5,000
Q3 2022 Nov 14, 2022	SELL	$0.56 - $6.98 $3,604 - $44,930	-6,437 Reduced 18.52%	28,313 $18,000
Q2 2022 Oct 27, 2022	BUY	$0.63 - $1.22 $6,124 - $11,860	9,722 Added 38.84%	34,750 $23,000
Q2 2022 Aug 15, 2022	BUY	$0.63 - $1.22 $6,124 - $11,860	9,722 Added 38.84%	34,750 $23,000
Q1 2022 Oct 27, 2022	SELL	$0.99 - $2.44 $9,624 - $23,721	-9,722 Reduced 27.98%	25,028 $28,000
Q1 2022 May 13, 2022	BUY	$0.99 - $2.44 $1,298 - $3,201	1,312 Added 5.53%	25,028 $28,000
Q4 2021 Feb 14, 2022	BUY	$2.18 - $3.93 $12,042 - $21,709	5,524 Added 30.36%	23,716 $52,000
Q3 2021 Nov 15, 2021	BUY	$2.71 - $4.35 $49,300 - $79,135	18,192 New	18,192 $55,000

88.1K

Ticker BSGM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,814,400
Market Cap $60.1M
Description
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.